I-124-CLR1404: Phase II started

Cellectar began an open-label, U.S. Phase II trial to compare single doses of 5 and 7.5 mCi IV I-124-CLR1404 in PET imaging vs. standard of care MRI in about 36 patients. I-124-CLR1404 is also in Phas...